What’s The Definition of “Selling”? GSK, Mylan And Apotex Relitigate Paxil Generic Settlements
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline argues that its patent infringement settlement agreement with Mylan did not prohibit it from selling an authorized generic to Apotex; alternatively, GSK wants the $106.7 million damages award reduced to $32.1 million.